CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
5.67
+0.24 (4.42%)
At close: Sep 16, 2025, 4:00 PM EDT
5.50
-0.17 (-3.00%)
After-hours: Sep 16, 2025, 7:31 PM EDT
CERO Market Cap
CERO has a market cap or net worth of $6.83 million as of September 16, 2025. Its market cap has decreased by -0.38% in one year.
Market Cap
6.83M
Enterprise Value
4.68M
1-Year Change
-0.38%
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from $222.99M to $6.83M, a decrease of -96.93%. That is a compound annual growth rate of -60.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 6.55M | -43.15% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |